by MyBiosource Editorial Team | Nov 14, 2018 | News
Table of Contents 1. Introduction 2. Challenges with annual vaccination 3. Strategies for generating safe and effective influenza vaccines 4. Challenges with antigenic drift and shift 5. Potential therapeutic use of recombinant forms of human anti-M2e monoclonal...
by MyBiosource Editorial Team | Nov 14, 2018 | News
Table of Contents I. Introduction A. 1918 influenza pandemic “Spanish Flu” B. Post-first pandemic influenza pandemics C. Reemergence of avian influenza A(H5N1) in Asia II. Efforts to Prepare for the Next Pandemic A. Expansion of influenza surveillance and...
by MyBiosource Editorial Team | Nov 14, 2018 | News
Table of Contents I. Introduction II. Universal influenza vaccine initiative (UIVI) III. Increasing number of clinical trials for developing a vaccine for treating influenza IV. Trivalent and quadrivalent flu vaccines V. Recommended egg-based quadrivalent and...
by MyBiosource Editorial Team | Nov 13, 2018 | News
Table of Contents 1. Influenza virus types A, B, C, and D 2. Discovery of Influenza D Virus 3. Prevalence rates of Influenza D Virus in different countries 4. Research funding for studying Influenza D Virus 5. Structure and genome of Influenza D Virus 6. Replication...
by MyBiosource Editorial Team | Nov 13, 2018 | News
Influenza C viruses of the family Orthomyx-oviridae differs from other members in its host range and pathogenicity. They are isolated almost exclusively from humans, although it has also been isolated from pigs and dogs. Influenza C viruses are endemic and...
by MyBiosource Editorial Team | Nov 13, 2018 | News
Table of Contents 1. Introduction 2. The global influenza surveillance system 3. The need for modifying the vaccine composition 4. The role of WHO Collaborating Centers and Essential Regulatory Laboratories 5. Guidelines for Clinical Management of Influenza Viruses 6....